Comparison of TKAs Using Force Plate Analysis

NCT ID: NCT04163445

Last Updated: 2021-08-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

48 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-11-11

Study Completion Date

2022-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate performance of two modern total knee arthroplasty designs using patient reported outcomes and force exhibited during various activities of daily living.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

48 patients with primary osteoarthritis of the knee who have been appropriately designated for treatment with a total knee arthroplasty (TKA) will be randomly assigned to one of two groups; one group (24 patients) will receive a Depuy Attune PCR knee implant, and one group (24 patients) will receive a MicroPort Orthopedics Evolution Medial Pivot knee implant utilizing standard and modern techniques. These two implants are designed to recreate the kinematic motion of a native knee articulation using different biomechanical design philosophies.

The patients will be monitored post-operatively using subjective and objective measures. Subjective patient reported outcomes will be analyzed using the Knee Injury and Osteoarthritis Outcome Score (KOOS), recorded preoperatively, as well as at 6 weeks, and 3 months postoperatively. Objective outcomes will be measured by having the patients perform four activities over force plates that will measure the amount of force a patient generates. The four activities will be: walking, standing from a seated position in a chair, squatting to a seated position, and walking up stairs. These objective measures will also be recorded preoperatively, 6 weeks, and 3 months postoperatively. The patient reported outcomes and the objective measures will then be compared between the two groups.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Knee Osteoarthritis Total Knee Arthroplasty Knee Injuries Knee Arthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors
The patient will be randomized to one of 2 treatment arms using a random number generator. The care provider will not be blinded as he will be implanting the device and following the patients' progress in clinic postoperatively, including radiographs which will show the implants. He will be blinded, however, to the results of the KOOS score and the data derived from the force plate analysis. The research assistants performing those assessments will be blinded to which treatment arm the patient belongs to.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Depuy Attune

Subjects will have been implanted with the Depuy Attune PCR TKA

Group Type ACTIVE_COMPARATOR

Depuy Synthes ATTUNE PCR TKA

Intervention Type DEVICE

Subjects will have been implanted with the Depuy Attune PCR TKA

MicroPort Medial Pivot

Subjects will have been implanted with the Microport Evolution Medial Pivot TKA

Group Type ACTIVE_COMPARATOR

MicroPort Orthopedics EVOLUTION Medial Pivot TKA

Intervention Type DEVICE

Subjects will have been implanted with the Microport Evolution Medial Pivot TKA

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MicroPort Orthopedics EVOLUTION Medial Pivot TKA

Subjects will have been implanted with the Microport Evolution Medial Pivot TKA

Intervention Type DEVICE

Depuy Synthes ATTUNE PCR TKA

Subjects will have been implanted with the Depuy Attune PCR TKA

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects who have been appropriately designated for treatment with a primary total knee arthroplasty
* Subjects who are willing to participate and are willing to sign the Informed Consent/HIPPA documents.

Exclusion Criteria

* Subjects who are unsuitable candidates for the two types of knee implants under investigation.
* Subjects with significant deformities or arthritis that might affect the procedural decision making, expected outcomes and functions are total knee arthroplasty.
* Subjects with significant comorbidities that might be at an increased risk of post-operative complications.
* Subjects who are unwilling to sign Informed Consent/HIPAA documents.
* Subjects who cannot perform the required activities after the surgery.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

MicroPort Orthopedics Inc.

INDUSTRY

Sponsor Role collaborator

Russell Nevins, M.D.

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Russell Nevins, M.D.

Chief of Surgery

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Russell Nevins

Role: PRINCIPAL_INVESTIGATOR

Desert Orthopedics

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Desert Orthopaedic Center

Las Vegas, Nevada, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Russell Nevins, MD

Role: CONTACT

702-731-1616

Kevin Sagers

Role: CONTACT

702-538-6929

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Russell Nevins, MD

Role: primary

702-731-1616

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

17IISK01 0

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.